The Recall Desk
SevereFDA (Drugs)·D-1686-2019·Announced 2019-08-14

RXQ Compounding Recalls Morphine Syringes Due to Sterility Concerns

RXQ Compounding LLC is recalling Morphine 1mg/mL in NaCl 0.9% 55mL syringes because the company cannot ensure the product is sterile.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility for an injectable medication, which poses a risk of serious adverse health consequences such as infection, meeting the criteria for a Severe rating.

Plain-English summary

RXQ Compounding LLC is recalling Morphine 1mg/mL in NaCl 0.9% 55mL syringes (NDC: 70731-0138-89). The recall is being conducted because the company lacks assurance of the sterility of the product. The affected product is a Schedule II controlled substance available in 55 mL vials.

The recall covers all lots within the expiration date. The product was distributed nationwide in the United States. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or healthcare provider for further instructions. The source text does not specify a specific date for the recall or the number of units affected.

The recalled product

Product
MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89
Manufacturer
RXQ Compounding LLC
Category
Drug — Injectable Medication
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 86 recalled by RXQ Compounding LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 86 products in this recall →

Related recalls

Same manufacturer · RXQ Compounding LLC

See all →

Same hazard · sterility

See all →